MHRA
The UK government has released a proposed regime on the regulation of medical devices in Great Britain, Northern Ireland and the European Union post Brexit.
The firm also announced a deal with a Fortune 200 company to launch gestational diabetes product in the US.
Google-backed 23andMe is finally relaunching its mail-order personal genome service -- just not in the United States.